Agaricus Blazei Mushroom Powder

References

– A. A. Soares, A. L. De Oliveira, A. B. Sá-Nakanishi et al., “Effects of an Agaricus blazei aqueous extract pretreatment on paracetamol-induced brain and liver injury in rats,” BioMed Research International, vol. 2013, Article ID 469180, 12 pages, 2013.
– A. B. D. Sá-Nakanishi, A. A. Soares, A. L. De Oliveira, J. Fernando Comar, R. M. Peralta, and A. Bracht, “Effects of treating old rats with an aqueous Agaricus blazei extract on oxidative and functional parameters of the brain tissue and brain mitochondria,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 563179, 13 pages, 2014.
– A. F. Da Silva, D. Sartori, F. C. MacEdo Jr., L. R. Ribeiro, M. H. P. Fungaro, and M. S. Mantovani, “Effects of β-glucan extracted from Agaricus blazei on the expression of ERCC5, CASP9, and CYP1A1 genes and metabolic profile in HepG2 cells,” Human and Experimental Toxicology, vol. 32, no. 6, pp. 647–654, 2013.
– Bellini MF, Giacomini NL, Eira AF, Ribeiro LR, Mantovani MS. Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO-k1 cells, studying different developmental phases of the mushroom. Toxicol In Vitro2003;17:465–9.
– Bernardshaw S, Hetland G, Ellertsen LK, Aaland Tryggestad AM, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation. 2005;29:147–153.
– Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AMA, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation. 2005;29(4–6):147–153.
– Bernardshaw S, Hetland G, Grinde B, Johnson E. An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model of fecal peritonitis. Shock. 2006;25(4):420–425.
– Bernardshaw S, Johnson E, Hetland G. An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice. Scandinavian Journal of Immunology. 2005;62(4):393–398.
– Bernardshaw S, Lyberg T, Hetland G, Johnson E. Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo . Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2007;115(6):719–725.
– Berven L, Karppinen P, Hetland G, Samuelsen AB. The polar high molecular weight fraction of the Agaricus blazei Murill extract, AndoSan™, reduces the activity of the tumor-associated protease, legumain, in RAW 264.7 cells. J Med Food. 2015 Apr;18(4):429–38.
– Chan Y, Chang T, Chan CH, Yeh YC, Chen CW, Shieh B, Li C. Immunomodulatory effect of Agaricus blazei Murill in Balb/cByJ mice. J Microbiol Immunol Infect. 2007;40:201–208.
– Chen L, Shao H. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease. Veterinary Immunology and Immunopathology. 2006;109(1-2):177–182.
– Chen L, Shao HJ, Su YB. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses. International Immunopharmacology. 2004;4(3):403–409.
– Ebina T, Fujimiya Y. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 1998;11:259–65.
– Ellertsen LK, Hetland G. An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clinical and Molecular Allergy. 2009;7, article no. 6.
– Ellertsen LK, Hetland G, Johnson E, Grinde B. Effect of a medicinal extract from Agaricus blazei Murill on gene expression in a human monocyte cell line as examined by microarrays and immuno assays. Int Immunopharmacol. 2006;6:133–143.
– Endo M, Beppu H, Akiyama H, et al. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochimica et Biophysica Acta. 2010;1800(7):669–673.
– F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008.
– Førland DT, Johnson E, Sætre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease. Scandinavian Journal of Immunology. 2011;73(1):66–75.
– Førland DT, Johnson E, Tryggestad AMA, Lyberg T, Hetland G. An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine. 2010;49(3):245–250.
– Fujimiya Y, Suzuki Y, Oshiman KI, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunology Immunotherapy. 1998;46(3):147–159.
– G. Aviello, J. M. Canadanovic-Brunet, N. Milic et al., “Potent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusa,” PLOS ONE, vol. 6, no. 5, Article ID e19628, 2011.
– G. Hetland, E. Johnson, T. Lyberg, S. Bernardshaw, A. M. A. Tryggestad, and B. Grinde, “Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer,” Scandinavian Journal of Immunology, vol. 68, no. 4, pp. 363–370, 2008.
– Gao L, Sun Y, Chen C, Xi Y, Wang J, Wang Z. Primary mechanism of apoptosis induction in a leukemia cell line by fraction
– Grinde B, Hetland G, Johnson E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. Int Immunopharmacol. 2006;6:1311–1314.
– Hetland G. Applicant/Inventor: Use of the mushroom Agaricus blazei Murill for the production of medicaments suitable for treating infections and allergies. WO 2005/065063 (Priority; Jan 2004)
– Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AMA, Grinde B. Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer. Scandinavian Journal of Immunology. 2008;68(4):363–370.
– Hetland G, Johnson E, Lyberg T, Kvalheim G. The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation. Adv Pharmacol Sci. 2011: 157015.
– Hsu CH, Hwang KC, Chiang YH, Chou P. The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. Journal of Alternative and Complementary Medicine. 2008;14(3):299–301.
– Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine. 2007;13(1):97–102.
– Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1→6)-β-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill (’Himematsutake’) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Japanese Journal of Pharmacology. 1994;66(2):265–271.
– Izawa S, Inoue Y. A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill. Appl Microbiol Biotechnol 2004;64:537–42.
– Johnson E, Førland DT, Sætre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol. 2009;69:242–250.
– K. Shimada, K. Fujikawa, K. Yahara, and T. Nakamura, “Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion,” Journal of Agricultural and Food Chemistry, vol. 40, no. 6, pp. 945–948, 1992.
– Kasai H, He LM, Kawamura M, Yang PT, Deng XW, Munkanta M, Yamashita A, Terunuma H, Hirama M, Horiuchi I, Natori T, Koga T, Amano Y, Yamaguchi N, Ito M. IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR) Evid Based Complement Alternat Med. 2004;1:259–267.
– Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186(2):267–73.
– Kerrigan RW. Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia. 2005;97:12–24.
– Kim GY, Lee MY, Lee HJ et al. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol 2005;5:1523–32.
– Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Science. 2004;95(9):758–764.
– Kobayashi H, Yoshida R, Kanada Y, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology. 2005;131(8):527–538.
– Kubo N, Myojin Y, Shimamoto F et al. Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei murill against X-irradiation in B6C3F1 mice: increased small intestinal.
– Kuo YC, Huang YL, Chen CC, Lin YS, Chuang KA, Tsai WJ. Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei. J Lab Clin Med. 2002;140:176–187.
– Lee IP, Kang BH, Roh JK, Kim JR. Lack of carcinogenicity of lyophilized Agaricus blazei Murill in a F344 rat two year bioassay. Food and Chemical Toxicology. 2008;46(1):87–95.
– M. F. Bellini, N. L. Giacomini, A. F. Eira, L. R. Ribeiro, and M. S. Mantovani, “Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO-k1 cells, studying different developmental phases of the mushroom,” Toxicology in Vitro, vol. 17, no. 4, pp. 465–469, 2003.
– M. Kozarski, A. Klaus, M. Niksic, D. Jakovljevic, J. P. F. G. Helsper, and L. J. L. D. Van Griensven, “Antioxidative and immunomodulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus,” Food Chemistry, vol. 129, no. 4, pp. 1667–1675, 2011.
– M. Radaković, N. Đelić, J. Stevanović et al., “Evaluation of the antigenotoxic effects of the royal sun mushroom, Agaricus brasiliensis (Higher basidiomycetes) in human lymphocytes treated with thymol in the comet assay,” International Journal of Medicinal Mushrooms, vol. 17, no. 4, pp. 321–330, 2015.
– Martins de Oliveira J, Jordão BQ, Ribeiro LR, Ferreira da Eira A, Mantovani MS. Anti-genotoxic effect of aqueous extracts of sun mushroom (Agaricus blazei Murill lineage 99/26) in mammalian cells in vitro. Food Chem Toxicol2002;40:1775–80.
– Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol. 2006;36:808–810.
– Murakawa K, Fukunaga K, Tanouchi M, Hosokawa M, Hossain Z, Takahashi K. Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Murill as an immune respond activator. Journal of Oleo Science. 2007;56(4):179–188.
– Nakajima A, Ishida T, Koga M, Takeuchi T, Mazda O, Takeuchi M. Effect of hot water extract from Agaricus blazei Murill on antibody-producing cells in mice. Int Immunopharmacol 2002;2:1205–11.
– Niu YC, Liu JC, Zhao XM, Wu XX. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo. Oncology Reports. 2009;21(1):145–152.
– Oh TW, Kim YA, Jang WJ, et al. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry. 2010;58(7):4113–4119.
– Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei . Biological and Pharmaceutical Bulletin. 2001;24(7):820–828.
– Oshiman K, Fujimiya Y, Ebina T, Suzuki I, Noji M. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Planta Med 2002;68:610–4.
– P. H. Gameiro, J. S. Nascimento, B. H. G. Rocha, C. F. B. Piana, R. A. Santos, and C. S. Takahashi, “Antimutagenic effect of aqueous extract from agaricus brasiliensis on culture of human lymphocytes,” Journal of Medicinal Food, vol. 16, no. 2, pp. 180–183, 2013.
– Pinheiro F, Faria RR, de Camargo JL, Spinardi-Barbisan AL, da Eira AF, Barbisan LF. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food Chem Toxicol. 2003 Nov;41(11):1543–50.
– R. C. Luiz, B. Q. Jordão, A. F. Da Eira, L. R. Ribeiro, and M. S. Mantovani, “Non-mutagenic or genotoxic effects of medicinal aqueous extracts from the Agaricus blazei mushroom in V79 cells,” Cytologia, vol. 68, no. 1, pp. 1–6, 2003.
– R. C. R. N. Menoli, M. S. Mantovani, L. R. Ribeiro, G. Speit, and B. Q. Jordão, “Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on V79 cells,” Mutation Research – Genetic Toxicology and Environmental Mutagenesis, vol. 496, no. 1-2, pp. 5–13, 2001.
– R. D. Delmanto, P. L. A. De Lima, M. M. Sugui et al., “Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide,” Mutation Research, vol. 496, no. 1-2, pp. 15–21, 2001.
– S. J. Huang and J.-L. Mau, “Antioxidant properties of methanolic extracts from Agaricus blazei with various doses of γ-irradiation,” LWT – Food Science and Technology, vol. 39, no. 7, pp. 707–716, 2006.
– S. Y. Tsai, H.-L. Tsai, and J.-L. Mau, “Antioxidant properties of Agaricus blazei, Agrocybe cylindracea, and Boletus edulis,” LWT—Food Science and Technology, vol. 40, no. 8, pp. 1392–1402, 2007.
– Shimizu S, Kitada H, Yokota H et al. Activation of the alternative complement pathway by Agaricus blazeiMurill. Phytomedicine 2002;9:536–45.
– Sodring M, Gunnes G, Paulsen JE. Spontaneous initiation, promotion, and progression of colorectal cancer in the novel A/J Min/+ mouse. Int J Cancer. 2016 Apr 15;138(8):1936–46.
– Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Structure and Function. 2001;26(2):103–108.
– Sorimachi K, Akimoto K, Koge T. Inhibitory Effect of Agaricus blazei Murill Components on Abnormal Collagen Fiber Formation in Human Hepatocarcinoma Cells. Biosci Biotechnol Biochem 2008;72:621–3.
– Sorimachi K, Ikehara Y, Maezato G et al. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci Biotechnol Biochem2001;65:1645–7.
– Suehiro M, Kishimoto S. Cheilitis due to Agaricus blazei Murill mushroom extract. Contact Derm. 2007;56:293–294.
– Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Ogawa N. Clinical efficacy of lentinan on neoplastic diseases. Adv Exp Med Biol 1983;166:181–7.
– Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. Journal of Nutrition. 2001;131(5):1409–1413.
– Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM et al. Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study. Biomed Res Int. 2015;2015:718539.
– Tangen J-M, Tryggestad AMA and Hetland G. Stimulation of human monocytic cells by the medicinal mushroom Agaricus blazei Murill induces expression of cell surface markers associated with activation and antigen presentation. Applied Scientific Reports. 2014; 1(1): 1.
– Tian X, Lun Z, Wang J, Ito H, Simura K. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill. J Lanzhou Med College 1994;20:169–71.
– Tryggestad AMA, Espevik T, Førland DT, Ryan L, Hetland G. The Medical Mushroom Agaricus blazei Murill Activates NF-κB via TLR2. 13th International Congress of Immunology, Rio de Janeiro, 2007: P2.23 INI-02 Signalling pathways of innate immune receptors; P1193.
– Xiaohui T, Lun Z, Wang J, et al. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill. Journal of Lanzhou Medical College. 1994;20:169–171.
– Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms of Agaricus blazeiMurill on the growth of prostate cancer in vitro and in vivo. Journal of Nutritional Biochemistry. 2009;20(10):753–764.
– Yuminamochi E, Koike T, Takeda K, Horiuchi I, Okumura K. Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill. Immunology. 2007;121:197–206.
– Z. da Rosa Guterres, M. S. Mantovani, A. F. da Eira, L. R. Ribeiro, and B. Q. Jordão, “Genotoxic and antigenotoxic effects of organic extracts of mushroom Agaricus blazei Murrill on V79 cells,” Genetics and Molecular Biology, vol. 28, no. 3, pp. 458–463, 2005.
– Z. R. Guterrez, M. S. Mantovani, A. F. Eira, L. R. Ribeiro, and B. Q. Jordão, “Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murrill in vitro,” Toxicology in Vitro, vol. 18, no. 3, pp. 301–309, 2004.
– Ziliotto L, Pinheiro F, Barbisan LF, Rodrigues MAM. Screening for in vitro and in vivo antitumor activities of the mushroom Agaricus blazei. Nutrition and Cancer, 2009;61(2), 245–250.